Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients B Petricevic, J Laengle, J Singer, M Sachet, J Fazekas, G Steger, ... Journal of translational medicine 11, 1-11, 2013 | 190 | 2013 |
AllergoOncology–the impact of allergy in oncology: EAACI position paper E Jensen‐Jarolim, HJ Bax, R Bianchini, M Capron, C Corrigan, M Castells, ... Allergy 72 (6), 866-887, 2017 | 85 | 2017 |
Generation of a canine anti-EGFR (ErbB-1) antibody for passive immunotherapy in dog cancer patients J Singer, J Fazekas, W Wang, M Weichselbaumer, M Matz, A Mader, ... Molecular cancer therapeutics 13 (7), 1777-1790, 2014 | 68 | 2014 |
Deletion of hypothetical wall teichoic acid ligases in Staphylococcus aureus activates the cell wall stress response V Dengler, PS Meier, R Heusser, P Kupferschmied, J Fazekas, S Friebe, ... FEMS microbiology letters 333 (2), 109-120, 2012 | 65 | 2012 |
AllergoOncology: opposite outcomes of immune tolerance in allergy and cancer E Jensen‐Jarolim, HJ Bax, R Bianchini, S Crescioli, TR Daniels‐Wells, ... Allergy 73 (2), 328-340, 2018 | 62 | 2018 |
IgE‐based immunotherapy of cancer: challenges and chances J Singer, E Jensen‐Jarolim Allergy 69 (2), 137-149, 2014 | 42 | 2014 |
Translating clinical trials from human to veterinary oncology and back I Fürdös, J Fazekas, J Singer, E Jensen-Jarolim Journal of Translational Medicine 13, 1-7, 2015 | 38 | 2015 |
Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody T Nagaya, S Okuyama, F Ogata, Y Maruoka, DW Knapp, SN Karagiannis, ... Oncotarget 9 (27), 19026, 2018 | 36 | 2018 |
Crosstalk of carcinoembryonic antigen and transforming growth factor-β via their receptors: comparing human and canine cancer E Jensen-Jarolim, J Fazekas, J Singer, G Hofstetter, K Oida, H Matsuda, ... Cancer immunology, immunotherapy 64, 531-537, 2015 | 33 | 2015 |
Canine macrophages can like human macrophages be in vitro activated toward the M2a subtype relevant in allergy I Herrmann, J Gotovina, J Fazekas-Singer, MB Fischer, K Hufnagl, ... Developmental & Comparative Immunology 82, 118-127, 2018 | 27 | 2018 |
Proof of concept study with an HER-2 mimotope anticancer vaccine deduced from a novel AAV-mimotope library platform J Singer, K Manzano-Szalai, J Fazekas, K Thell, A Bentley-Lukschal, ... Oncoimmunology 5 (7), e1171446, 2016 | 24 | 2016 |
Why man's best friend, the dog, could also benefit from an anti‑HER-2 vaccine J Fazekas, I Fürdös, J Singer, E Jensen‑Jarolim Oncology letters 12 (4), 2271-2276, 2016 | 22 | 2016 |
Functionally active Fc mutant antibodies recognizing cancer antigens generated rapidly at high yields KM Ilieva, J Fazekas-Singer, DY Achkova, TS Dodev, S Mele, S Crescioli, ... Frontiers in Immunology 8, 1112, 2017 | 20 | 2017 |
AllergoOncology: high innate IgE levels are decisive for the survival of cancer-bearing mice J Singer, G Achatz-Straussberger, A Bentley-Lukschal, J Fazekas-Singer, ... World Allergy Organization Journal 12 (7), 100044, 2019 | 17 | 2019 |
Janus-faced Acrolein prevents allergy but accelerates tumor growth by promoting immunoregulatory Foxp3+ cells: Mouse model for passive respiratory exposure F Roth-Walter, C Bergmayr, S Meitz, S Buchleitner, C Stremnitzer, ... Scientific reports 7 (1), 45067, 2017 | 17 | 2017 |
Nitration of β-lactoglobulin but not of ovomucoid enhances anaphylactic responses in food allergic mice SC Diesner, C Schultz, C Ackaert, GJ Oostingh, A Ondracek, ... PloS one 10 (5), e0126279, 2015 | 15 | 2015 |
AllergoOncology: Generating a canine anticancer IgE against the epidermal growth factor receptor J Fazekas-Singer, J Singer, KM Ilieva, M Matz, I Herrmann, E Spillner, ... Journal of Allergy and Clinical Immunology 142 (3), 973-976. e11, 2018 | 14 | 2018 |
AllergoOncology: Expression platform development and functional profiling of an anti‐HER2 IgE antibody KM Ilieva, J Fazekas‐Singer, HJ Bax, S Crescioli, L Montero‐Morales, ... Allergy 74 (10), 1985, 2019 | 12 | 2019 |
Bidirectional regulation of COX-2 expression between cancer cells and macrophages MI Carvalho, R Bianchini, J Fazekas-Singer, I Herrmann, I Flickinger, ... Anticancer research 38 (5), 2811-2817, 2018 | 10 | 2018 |
Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology? E Jensen-Jarolim, J Singer Clinical and experimental allergy: journal of the British Society for …, 2011 | 10 | 2011 |